Literature DB >> 9764589

Allelotype analysis of oesophageal adenocarcinoma: loss of heterozygosity occurs at multiple sites.

K Dolan1, J Garde, J Gosney, M Sissons, T Wright, A N Kingsnorth, S J Walker, R Sutton, S J Meltzer, J K Field.   

Abstract

Deletions of tumour-suppressor genes can be detected by loss of heterozygosity (LOH) studies, which were performed on 23 cases of adenocarcinoma of the oesophagus, using 120 microsatellite primers covering all non-acrocentric autosomal chromosome arms. The chromosomal arms most frequently demonstrating LOH were 3p (64% of tumours), 5q (45%), 9p (52%), 11p (61%), 13q (50%), 17p (96%), 17q (55%) and 18q (70%). LOH on 3p, 9p, 13q, 17p and 18q occurred mainly within the loci of the VHL, CDKN2, Rb, TP53 and DCC tumour-suppressor genes respectively. LOH on 5q occurred at the sites of the MSH3 mismatch repair gene and the APC tumour-suppressor gene. 11p15.5 and 17q25-qter represented areas of greatest LOH on chromosomes 11p and 17q, and are putative sites of novel tumour-suppressor genes. LOH on 9p was significantly associated with LOH on 5q, and tumours demonstrating LOH at both the CDKN2 (9p21) and MSH3 (5q11-q12) genes had a significantly higher fractional allele loss than those retaining heterozygosity at these sites. Six of nine carcinomas displaying microsatellite alterations also demonstrated LOH at CDKN2, which may be associated with widespread genomic instability. Overall, there are nine sites of LOH associated with oesophageal adenocarcinoma.

Entities:  

Mesh:

Year:  1998        PMID: 9764589      PMCID: PMC2063115          DOI: 10.1038/bjc.1998.607

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  25 in total

1.  Only patients with dysplasia progress to adenocarcinoma in Barrett's oesophagus.

Authors:  M Miros; P Kerlin; N Walker
Journal:  Gut       Date:  1991-12       Impact factor: 23.059

2.  A region of interstitial 17q25 allelic loss in ovarian tumors coincides with a defined region of loss in breast tumors.

Authors:  L M Kalikin; T S Frank; S M Svoboda-Newman; J C Wetzel; K A Cooney; E M Petty
Journal:  Oncogene       Date:  1997-04-24       Impact factor: 9.867

3.  Allelotype analysis in osteosarcomas: frequent allele loss on 3q, 13q, 17p, and 18q.

Authors:  T Yamaguchi; J Toguchida; T Yamamuro; Y Kotoura; N Takada; N Kawaguchi; Y Kaneko; Y Nakamura; M S Sasaki; K Ishizaki
Journal:  Cancer Res       Date:  1992-05-01       Impact factor: 12.701

4.  Allelotype of colorectal carcinomas.

Authors:  B Vogelstein; E R Fearon; S E Kern; S R Hamilton; A C Preisinger; Y Nakamura; R White
Journal:  Science       Date:  1989-04-14       Impact factor: 47.728

5.  Allelotype analysis of esophageal squamous cell carcinoma.

Authors:  I Shibagaki; Y Shimada; T Wagata; M Ikenaga; M Imamura; K Ishizaki
Journal:  Cancer Res       Date:  1994-06-01       Impact factor: 12.701

6.  Adenocarcinoma and Barrett's esophagus. An overrated risk?

Authors:  S J Spechler; A H Robbins; H B Rubins; M E Vincent; T Heeren; W G Doos; T Colton; E M Schimmel
Journal:  Gastroenterology       Date:  1984-10       Impact factor: 22.682

7.  Influence of preoperative radiotherapy on DNA ploidy in squamous cell carcinomas of the oesophagus.

Authors:  R Porschen; G Bevers; U Remy; S Schauseil; F Borchard
Journal:  Gut       Date:  1993-08       Impact factor: 23.059

8.  Barrett's esophagus. Prevalence and incidence of adenocarcinoma.

Authors:  W A Williamson; F H Ellis; S P Gibb; D M Shahian; H T Aretz; G J Heatley; E Watkins
Journal:  Arch Intern Med       Date:  1991-11

9.  DNA ploidy in squamous oesophageal carcinoma.

Authors:  T N Walsh; T Dorman; O Droogan; B Curran; D O Hourihane; M Leader; T P Hennessy
Journal:  Surg Oncol       Date:  1992-02       Impact factor: 3.279

10.  Deletion of 17p and amplification of the int-2 gene in esophageal carcinomas.

Authors:  T Wagata; K Ishizaki; M Imamura; Y Shimada; M Ikenaga; T Tobe
Journal:  Cancer Res       Date:  1991-04-15       Impact factor: 12.701

View more
  20 in total

Review 1.  Molecular biology of Barrett's adenocarcinoma.

Authors:  B P Wijnhoven; H W Tilanus; W N Dinjens
Journal:  Ann Surg       Date:  2001-03       Impact factor: 12.969

Review 2.  Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.

Authors:  J A Jankowski; N A Wright; S J Meltzer; G Triadafilopoulos; K Geboes; A G Casson; D Kerr; L S Young
Journal:  Am J Pathol       Date:  1999-04       Impact factor: 4.307

Review 3.  Early events during neoplastic progression in Barrett's esophagus.

Authors:  Brian J Reid
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

Review 4.  Screening and surveillance for Barrett's esophagus: current issues and future directions.

Authors:  Sung E Choi; Chin Hur
Journal:  Curr Opin Gastroenterol       Date:  2012-07       Impact factor: 3.287

Review 5.  Genetic Insights in Barrett's Esophagus and Esophageal Adenocarcinoma.

Authors:  Brian J Reid; Thomas G Paulson; Xiaohong Li
Journal:  Gastroenterology       Date:  2015-07-21       Impact factor: 22.682

6.  Predictors of progression in Barrett's esophagus II: baseline 17p (p53) loss of heterozygosity identifies a patient subset at increased risk for neoplastic progression.

Authors:  B J Reid; L J Prevo; P C Galipeau; C A Sanchez; G Longton; D S Levine; P L Blount; P S Rabinovitch
Journal:  Am J Gastroenterol       Date:  2001-10       Impact factor: 10.864

7.  Molecular cytogenetic evaluation of gastric cardia adenocarcinoma and precursor lesions.

Authors:  H van Dekken; J C Alers; P H Riegman; C Rosenberg; H W Tilanus; K Vissers
Journal:  Am J Pathol       Date:  2001-06       Impact factor: 4.307

8.  Genome-wide detection of allelic imbalance using human SNPs and high-density DNA arrays.

Authors:  R Mei; P C Galipeau; C Prass; A Berno; G Ghandour; N Patil; R K Wolff; M S Chee; B J Reid; D J Lockhart
Journal:  Genome Res       Date:  2000-08       Impact factor: 9.043

9.  Single nucleotide polymorphism-based genome-wide chromosome copy change, loss of heterozygosity, and aneuploidy in Barrett's esophagus neoplastic progression.

Authors:  Xiaohong Li; Patricia C Galipeau; Carissa A Sanchez; Patricia L Blount; Carlo C Maley; Jessica Arnaudo; Daniel A Peiffer; Dmitry Pokholok; Kevin L Gunderson; Brian J Reid
Journal:  Cancer Prev Res (Phila)       Date:  2008-11

10.  Malignant tumors and forensics--dilemmas and proposals.

Authors:  Zoran Budimlija; Connie Lu; Grace Axler-DiPerte; Jessica Seifarth; Dorota Popiolek; Franz Fogt; Mechthild Prinz
Journal:  Croat Med J       Date:  2009-06       Impact factor: 1.351

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.